IRIS
CRISTAUDO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.038
EU - Europa 97
AS - Asia 21
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.163
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.037
IT - Italia 22
DE - Germania 13
IE - Irlanda 13
CN - Cina 12
GB - Regno Unito 10
BE - Belgio 9
FR - Francia 7
UA - Ucraina 7
RU - Federazione Russa 6
BR - Brasile 5
SE - Svezia 5
JP - Giappone 3
HK - Hong Kong 2
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
EU - Europa 1
FI - Finlandia 1
GR - Grecia 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.163
Salva come PNG Salva come JPEG
Città #
Wilmington 386
Houston 253
Woodbridge 162
Chandler 42
Fairfield 38
Ashburn 23
Ann Arbor 21
Seattle 20
Cambridge 18
Rome 12
Dublin 11
Dearborn 10
Brussels 9
Medford 8
New York 8
Beijing 4
Lawrence 4
São Paulo 4
Jacksonville 3
Kunming 3
Palo Alto 3
San Francisco 3
Hong Kong 2
London 2
San Diego 2
Almaty 1
Bratislava 1
Caserta 1
Hebei 1
Hounslow 1
Jinan 1
Johannesburg 1
Kilburn 1
Kraków 1
Los Angeles 1
Nanchang 1
Nanjing 1
Norwalk 1
Redmond 1
Redwood City 1
Saint Petersburg 1
Seoul 1
Thessaloníki 1
Tokyo 1
Toronto 1
Xian 1
Totale 1.072
Salva come PNG Salva come JPEG
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 435
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 291
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 280
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study 163
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 9
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 6
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 5
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 3
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 3
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 3
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 3
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 3
Totale 1.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201947 0 0 0 0 0 0 0 0 0 0 25 22
2019/2020392 21 22 19 26 25 34 52 44 46 36 30 37
2020/2021277 29 36 28 41 25 33 33 33 2 8 3 6
2021/202259 7 4 1 4 0 4 5 2 8 7 5 12
2022/202396 22 10 5 14 8 14 6 8 5 2 1 1
2023/202453 4 1 0 0 2 8 1 0 2 35 0 0
Totale 1.204